For which infants with viral bronchiolitis could it be deemed appropriate to use albuterol, at least on a therapeutic trial basis?

Rodriguez-Martinez, Carlos E; Nino, Gustavo; Castro-Rodriguez, Jose A; Acuña-Cordero, Ranniery; Sossa-Briceño, Monica P; Midulla, Fabio.
Allergol. immunopatol ; 49(1): 153-158, ene.-feb. 2021. tab
Artículo en Inglés | IBECS (España) | ID: ibc-199237

Documentos relacionados

  1. Predictors for the prescription of albuterol in infants hospitalized for viral bronchiolitis.
  2. Risk Factors for Respiratory Syncytial Virus Bronchiolitis Admissions.
  3. Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity.
  4. Bronchodilator response during acute viral bronchiolitis in infancy.
  5. Reply to Plötz et al.
  6. Innate immune dysfunction in RSV: what is the role of ventilation?
  7. Elevated Levels of Type 2 Respiratory Innate Lymphoid Cells in Human Infants with Severe Respiratory Syncytial Virus Bronchiolitis.
  8. For which infants with viral bronchiolitis could it be deemed appropriate to use albuterol, at least on a therapeutic trial basis?
  9. Respiratory syncytial virus binds and undergoes transcription in neutrophils from the blood and airways of infants with severe bronchiolitis.
  10. More on Viral Bronchiolitis in Children.